Related Experiment Video
Updated: May 5, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Strength of associations between regional brain volumes and dual decline in gait and memory
Sadhani Karunarathna1, Monique Breslin1, Jane Alty2
1Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Background:
Dual decline in gait and memory is associated with a higher risk of dementia. However, little is known about specific brain regions and their association with dual decline. Therefore, this study examined the strength of associations between baseline regional brain volumes and dual decline in gait speed and memory.
Methods:
Participants aged over 60 years were randomly selected from the Southern Tasmanian electoral roll. Participants (n = 266) were classified into four groups depending on tertiles of annual decline in gait speed and delayed memory recall: non-decline, gait-only decline, cognitive-only decline, and dual decline. Multinomial logistic regression was used to examine the strength of associations between baseline regional brain volumes and the four groups.
Results:
The mean age of participants was 70.9 ± SD 6.7 years. For the dual decline group, eight regions (in order of strength - orbitofrontal cortex, middle frontal gyrus, superior frontal gyrus, thalamus, anterior cingulate cortex, brainstem, inferior temporal gyrus and hippocampus) had relative risk ratios below 0.60 for a 1 SD increase in volume. For gait-only and cognitive-only decline, only the thalamus and cerebellum respectively, had relative risk ratios below 0.60.
Conclusions:
In this study, we observed that smaller volumes in regions related to memory, executive function, motor, and sensory-motor integration had the strongest associations with dual decline.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
Dementia l: Introduction

